Publicado 4 números por año
ISSN Imprimir: 1050-6934
ISSN En Línea: 1940-4379
Indexed in
Breast Implant Surveillance Reports to the U.S. Food and Drug Administration: Maternal-Child Health Problems
SINOPSIS
There is continuing concern that women who receive breast implants may be at increased risk for adverse reproductive outcomes or experience problems with breastfeeding. It is unknown whether exposure to biomaterials in breast implants may have teratogenic effects or leach into breast milk causing postnatal problems.
We studied the Food and Drug Administration (FDA) experience by analyzing a case series of adverse event reports received and entered into the FDA's Manufacturer and User Facility Device Experience (MAUDE) database or the Device Experience Network (DEN) database by December 31, 2002 regarding women with breast implants. Reports were critically reviewed for lactation difficulties, reproductive problems (spontaneous abortion, delayed conception) and medical conditions among offspring, including neonatal, infant, and childhood diseases and congenital defects that were attributed to implants.
We identified 339 reports that described maternal-child adverse events. Nearly half of these reports (46%) described actual problems with breastfeeding or expressed concern that implants would be unsafe or interfere with breastfeeding. Forty-four percent of reports (n = 149) described either nonspecific or specific signs, symptoms, or illnesses in children. An additional 3.5% of reports (n = 12) detailed a congenital anomaly believed by the reporter to be caused by breast implants.
-
Spear Scott L, Hedén Per, Allergan’s silicone gel breast implants, Expert Review of Medical Devices, 4, 5, 2007. Crossref
-
Cunha Burke A., Babu Jacob, Eisenstein Lawrence, Pseudomonas aeruginosa Infection Associated With a Breast Implant, Infectious Diseases in Clinical Practice, 16, 4, 2008. Crossref
-
GURTCHEFF SHAWN E., Introduction to the MAUDE Database, Clinical Obstetrics & Gynecology, 51, 1, 2008. Crossref
-
Kjøller Kim, Friis Søren, Lipworth Loren, McLaughlin Joseph K., Olsen Jørgen H., Adverse Health Outcomes in Offspring of Mothers with Cosmetic Breast Implants: A Review, Plastic and Reconstructive Surgery, 120, Supplement 1, 2007. Crossref
-
Keizers Peter H.J., Vredenbregt Marjo J., Bakker Frank, de Kaste Dries, Venhuis Bastiaan J., Chemical fingerprinting of silicone-based breast implants, Journal of Pharmaceutical and Biomedical Analysis, 102, 2015. Crossref
-
Woo Emily Jane, Re: A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned, The Spine Journal, 11, 8, 2011. Crossref
-
Mansel R.E., Webster D.J.T., Sweetland H.M., Hughes L.E., Gower-Thomas K., Evans D.G.R., Cody H.S., Congenital and growth disorders, in Hughes, Mansel & Webster's Benign Disorders and Diseases of the Breast, 2009. Crossref
-
Pavlov-Dolijanovic Slavica, Vujasinovic Stupar Nada, Women with silicone breast implants and autoimmune inflammatory syndrome induced by adjuvants: description of three patients and a critical review of the literature, Rheumatology International, 37, 8, 2017. Crossref
-
Aslani Parisa, Hamrosi Kim, Tong Vivien, Chen Timothy F., Cook Jane, Fois Romano, McGarry Theresa, Moore Carter, Peters Rodney, Spagnardi Sarah, Whitelock Karen, Consumer opinions on adverse events associated with medical devices, Research in Social and Administrative Pharmacy, 15, 5, 2019. Crossref
-
Dashtimoghadam Erfan, Fahimipour Farahnaz, Keith Andrew N., Vashahi Foad, Popryadukhin Pavel, Vatankhah-Varnosfaderani Mohammad, Sheiko Sergei S., Injectable non-leaching tissue-mimetic bottlebrush elastomers as an advanced platform for reconstructive surgery, Nature Communications, 12, 1, 2021. Crossref